Page 171 - Neuropsychiatric.indd

87. Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA. Use of nonsteroidal
anti-inflammatory drugs: an update for clinicians: a scientific statement from the American

Heart Association. Circulation. 2007;115(12):1634-42.
88. Gunter BR, Butler KA, Wallace RL, Smith SM, Harirforoosh S. Non-steroidal anti-
inflammatory drug-induced cardiovascular adverse events: a meta-analysis. J Clin Pharm
Ther. 2017;42(1):27-38.

89. Jackson JW, Schneeweiss S, VanderWeele TJ, Blacker D. Quantifying the role of adverse
events in the mortality difference between first and second-generation antipsychotics in
older adults: systematic review and meta-synthesis. PLoS One. 2014;9(8):e105376.

90. Imitrex (sumatriptan). Product information. [accessed 29 November 2020]. Available from:
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020132s024s026lbl.pdf
91. Cafergot (ergotamine and caffeine). Product information. [accessed 29 November 2020].
Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label /2002/ 9000s22s
23lbl.pdf

92. Viagra (sildenafil). Product information. [accessed 29 November 2020]. Available from:
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/20895s039s042lbl.pdf
93. Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ, et al. 2014

ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and
management of patients with stable ischemic heart disease: a report of the American
College of Cardiology/American Heart Association Task Force on Practice Guidelines, and
the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses

Association, Society for Cardiovascular Angiography and Interventions, and Society of
Thoracic Surgeons. J Am Coll Cardiol. 2014;64(18):1929-49.
94. Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, et al. 2014
AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary

Syndromes: a report of the American College of Cardiology/American Heart Association
Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64(24):e139-228.
95. Yildirim U, Gulel O, Soylu K, Yuksel S, Sahin M. Steroid-induced recurrent myocardial
ischemia. Rev Port Cardiol. 2014;33(7-8):473.e1-4.

96. Spinler SA, Silvestry FE. Chapter 29 Valvular and pericardial heart disease. In: Tisdale JE et
al., eds. Drug-Induced Diseases: Prevention, Detection, and Management. 3rd ed. United
States: American Society of Health-System Pharmacists, Inc., 2018.
97. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, et al. 2020 ACC/AHA

Guideline for the management of patients with valvular heart disease: executive summary:
A report of the American College of Cardiology/American Heart Association Joint
Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e35-e71.

150
150